Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin.
Magis-Escurra C, Later-Nijland HM, Alffenaar JW, Broeders J, Burger DM, van Crevel R, Boeree MJ, Donders AR, van Altena R, van der Werf TS, Aarnoutse RE.
Magis-Escurra C, et al. Among authors: donders ar.
Int J Antimicrob Agents. 2014 Sep;44(3):229-34. doi: 10.1016/j.ijantimicag.2014.04.019. Epub 2014 Jun 9.
Int J Antimicrob Agents. 2014.
PMID: 24985091